IL13RA2 Protein (Fc Tag)
-
- Target Alle IL13RA2 Proteine anzeigen
- IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
- Protein-Typ
- Recombinant
- Biologische Aktivität
- Active
-
Spezies
- Ratte
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses IL13RA2 Protein ist gelabelt mit Fc Tag.
- Verwendungszweck
- Recombinant Rat IL13RA2/CD213A2 Protein (Fc Tag)(Active)
- Sequenz
- Met1-Lys336
- Produktmerkmale
- A DNA sequence encoding the rat IL13RA2 (Q8VHK6) (Met1-Lys336) was expressed, fused with the Fc region of human IgG1 at the C-terminus.
- Reinheit
- > 90 % as determined by SDS-PAGE
- Endotoxin-Niveau
- < 1.0 EU per μg of the protein as determined by the LAL method
- Biological Activity Comment
- Measured by its ability to inhibit IL13-dependent proliferation of TF-1 human erythroleukemic cells.The ED50 for this effect is typically 0.005-0.03 μg/mL.
- Top Product
- Discover our top product IL13RA2 Protein
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Please refer to the printed manual for detailed information.
- Buffer
- Lyophilized from sterile PBS, pH 7.4
- Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
-
- Target
- IL13RA2 (Interleukin 13 Receptor, alpha 2 (IL13RA2))
- Andere Bezeichnung
- IL13RA2/CD213A2 (IL13RA2 Produkte)
- Synonyme
- il-13ra2 Protein, sb:cb602 Protein, si:dkeyp-110c7.6 Protein, CD213A2 Protein, CT19 Protein, IL-13R Protein, IL13BP Protein, CD213a2 Protein, IL-13R-alpha-2 Protein, IL13RA2 Protein, interleukin 13 receptor, alpha 2 Protein, interleukin 13 receptor subunit alpha 2 Protein, interleukin 13 receptor subunit alpha 2 S homeolog Protein, il13ra2 Protein, IL13RA2 Protein, il13ra2.S Protein, Il13ra2 Protein
- Hintergrund
-
Background: Interleukin-13 receptor subunit alpha-2 (IL13RA2/IL-13RA2) is also known as also known as cluster of differentiation 213A2 (CD213A2), IL-13 receptor subunit alpha-2, IL-13R subunit alpha-2, and IL-13RA2. The IL13RA2 is often overexpressed in brain tumors, making Il13ra2 one of the vaccine targets for immunotherapy of glioma. IL13RA2/IL-13RA2 is a cancer-associated receptor that is present in greater than 80% of High Grade Astrocytomas (HGA) and has recently been recognized as a cytokine that predisposes breast cancer cells to metastasize. Expression of IL13Rα2 was rapidly lost from the surface of transduced cells grown in culture. The loss appeared to be related to ligands present in fetal bovine serum in the medium. None of the malignant glioma cell lines cultivated in vitro and tested to date exhibited the IL13Rα2 receptor. A recombinant virus (R5111) enters cells via its interaction with the IL13Rα2 receptor in a manner that cannot be differentiated from the interaction of wild-type virus with its receptors.
Synonym: IL13R;IL13RA2
- Molekulargewicht
- 63.4 kDa
- UniProt
- Q8VHK6
-